Last reviewed · How we verify
NCT07483593
Baseline Gastric Volume in Diabetic vs Non-Diabetic Patients
trial testing Gastric Ultrasound in Gastric Volume in 220 participants. Not yet recruiting.
15 August 2026
Quick facts
| Lead sponsor | Kocaeli University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 220 |
| Start date | 20 April 2026 |
| Primary completion | 15 August 2026 |
| Estimated completion | 15 November 2026 |
| Sites | 2 locations across Turkey (Türkiye) |
Drugs / interventions tested
- Gastric Ultrasound
Conditions studied
- Gastric Volume — all drugs for Gastric Volume →
- Preoperative Fasting — all drugs for Preoperative Fasting →
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Kocaeli University
Who can join
Adults 18 to 75, any sex, with Gastric Volume or Preoperative Fasting. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
During the preoperative preparation process, the fasting period for anesthesia is planned according to guidelines. According to standard guidelines, a fasting period of at least 2 hours is recommended for clear liquids, at least 6 hours for light meals, and at least 8 hours for a full meal. However, it has been reported that these guidelines are valid for healthy patients. It is thought that the planned fasting periods may vary in diabetic patients due to delayed gastric emptying. This study aims to calculate gastric volume under ultrasonography guidance and compare it with fasting time.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07483593
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Gastric Ultrasound
Trials testing the same drug.
- NCT07421661 — Effect of Epilepsy and Antiepileptic Drug Therapy on Gastric Motility and Emptying With Point-Of-Care Gastric Ultrasound · not yet recruiting
- NCT07251803 — GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound · recruiting
- NCT06987669 — Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users · not yet recruiting
- NCT06666049 — Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist (Multicentric) · recruiting
- NCT06420739 — The Semaglutide Study · active not recruiting
Other Kocaeli University trials
Trials by the same sponsor.
- NCT06737887 — The Effect of Preoperative Stoma Simulation on Anxiety and Postoperative Adaptation · NA · recruiting
- NCT07536659 — Evaluation of Serum Autophagic Biomarkers in the Acute Response to Walking and Cycling in Healthy Male Individuals · enrolling by invitation
- NCT07482696 — Electromyographic Biofeedback Therapy in Patients With Dyssynergic Defecation · NA · not yet recruiting
- NCT07497945 — Optic Nerve Sheath Diameter for Predicting Post-Dural Puncture Headache in Cesarean Section Patients · not yet recruiting
- NCT07452874 — Community-Based Occupational Therapy for Syrian Refugees to Improve Social Participation and Occupational Justice · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07483593 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kocaeli University
- Last refreshed: 19 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07483593.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing